These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 15306691)
1. Is siRNA the tool of the future for in vivo mammalian gene research? The experts speak out. Ventura B Physiol Genomics; 2004 Aug; 18(3):252-4. PubMed ID: 15306691 [No Abstract] [Full Text] [Related]
2. Gene discovery by ribozyme and siRNA libraries. Akashi H; Matsumoto S; Taira K Nat Rev Mol Cell Biol; 2005 May; 6(5):413-22. PubMed ID: 15956980 [TBL] [Abstract][Full Text] [Related]
3. Vector-based RNAi approaches for stable, inducible and genome-wide screens. Fewell GD; Schmitt K Drug Discov Today; 2006 Nov; 11(21-22):975-82. PubMed ID: 17055406 [TBL] [Abstract][Full Text] [Related]
4. Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing. Luo Q; Kang Q; Song WX; Luu HH; Luo X; An N; Luo J; Deng ZL; Jiang W; Yin H; Chen J; Sharff KA; Tang N; Bennett E; Haydon RC; He TC Gene; 2007 Jun; 395(1-2):160-9. PubMed ID: 17449199 [TBL] [Abstract][Full Text] [Related]
6. Screening of siRNA target sequences by using fragmentized DNA. Kasim V; Taira K; Miyagishi M J Gene Med; 2006 Jun; 8(6):782-91. PubMed ID: 16532512 [TBL] [Abstract][Full Text] [Related]
7. Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo. Kang CS; Zhang ZY; Jia ZF; Wang GX; Qiu MZ; Zhou HX; Yu SZ; Chang J; Jiang H; Pu PY Cancer Gene Ther; 2006 May; 13(5):530-8. PubMed ID: 16410821 [TBL] [Abstract][Full Text] [Related]
9. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors. Sun Y; Li Z; Li L; Li J; Liu X; Li W Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648 [TBL] [Abstract][Full Text] [Related]
10. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells. Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668 [TBL] [Abstract][Full Text] [Related]
11. Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA. Sabbioni S; Callegari E; Manservigi M; Argnani R; Corallini A; Negrini M; Manservigi R Gene Ther; 2007 Mar; 14(5):459-64. PubMed ID: 17051250 [TBL] [Abstract][Full Text] [Related]
12. Using RNAi in the clinic. Dev KK IDrugs; 2006 Apr; 9(4):279-82. PubMed ID: 16596482 [TBL] [Abstract][Full Text] [Related]
13. Short interfering RNA (siRNA): tool or therapeutic? Cejka D; Losert D; Wacheck V Clin Sci (Lond); 2006 Jan; 110(1):47-58. PubMed ID: 16336204 [TBL] [Abstract][Full Text] [Related]
14. Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis. Schiffelers RM; Xu J; Storm G; Woodle MC; Scaria PV Arthritis Rheum; 2005 Apr; 52(4):1314-8. PubMed ID: 15818667 [TBL] [Abstract][Full Text] [Related]
15. Small interfering RNA-mediated functional silencing of vasopressin V2 receptors in the mouse kidney. Hassan A; Tian Y; Zheng W; Ji H; Sandberg K; Verbalis JG Physiol Genomics; 2005 May; 21(3):382-8. PubMed ID: 15784697 [TBL] [Abstract][Full Text] [Related]
16. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity. Akhtar S; Benter I Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774 [TBL] [Abstract][Full Text] [Related]
17. Small interfering RNA for experimental cancer therapy. Tong AW; Zhang YA; Nemunaitis J Curr Opin Mol Ther; 2005 Apr; 7(2):114-24. PubMed ID: 15844618 [TBL] [Abstract][Full Text] [Related]
18. Effective gene suppression using small interfering RNA in hard-to-transfect human T cells. Yin J; Ma Z; Selliah N; Shivers DK; Cron RQ; Finkel TH J Immunol Methods; 2006 May; 312(1-2):1-11. PubMed ID: 16603179 [TBL] [Abstract][Full Text] [Related]